Analysts' Analyst

Sharing the latest in health, science, and current events. Pro-vaccine, fact-driven, and here to highlight what matters. 💉🌍 #PublicHealth #ScienceNews

[Analysts' Analyst @AnalystsAnalyst]

HHS Secretary RFK Jr. pushing vitamin A as a measles treatment is beyond reckless—it's dangerous. The science is clear: the MMR vaccine is the only reliable way to prevent measles. Misinformation like this puts lives at risk.

https://t.co/vpEKRYSh8P
#rfk #PublicHealth #vaccines

[Analysts' Analyst @AnalystsAnalyst]

Arizona's low vaccination rates raise concerns about potential measles outbreaks, similar to recent cases in Texas. We need a 95% vaccination rate to prevent the spread of this highly contagious disease.

https://t.co/CRSoshvdPj
#vaccine #infection #disease #Arizona

[Analysts' Analyst @AnalystsAnalyst]

GeoVax is leading the charge in biodefense! Their MVA-based vaccines are now recognized as vital components of the U.S. biodefense strategy. Discover how they're enhancing national security.

https://t.co/JIU8BHItKY
#GeoVax #biotech #vaccines #vaccineswork

[Analysts' Analyst @AnalystsAnalyst]

Amid rising measles cases, experts emphasize that vitamin A supplements can't replace the MMR vaccine's proven protection. Vaccination remains our best defense against this highly contagious disease.

https://t.co/i6VfcVbLdp #vaccine #rfkjrconfirmation #Trump #FDA #PublicHealth

[Analysts' Analyst @AnalystsAnalyst]

GeoVax spotlights the power of MVA-based vaccines in tackling emerging health threats. Diversifying vaccine strategies could be key to stronger, broader protection. Dive into the details 👉

https://t.co/S7lrVNfhPb

#YahooFinance #GeoVax #PublicHealth

[Analysts' Analyst @AnalystsAnalyst]

Vaccines are humanity's greatest invention, teaching our bodies to defend against specific microbes without the risk of infection. They activate antibodies and T cells, preparing us for future encounters. Learn more about how vaccines work:
https://t.co/54f3NtErqb
#disease

[Analysts' Analyst @AnalystsAnalyst]

GeoVax will showcase its latest advancements and future plans at the Emerging Growth Conference on February 19, 2025. This presentation aims to provide investors and stakeholders with insights into the company's progress and upcoming milestones.

#GeoVax
https://t.co/cFiYNmX2JR

[Analysts' Analyst @AnalystsAnalyst]

GeoVax is improving America's biosecurity by advancing domestic vaccine production capabilities to strengthen national readiness against emerging infectious diseases.

#vaccine #biotech
https://t.co/Gb5vfinW4v

[Analysts' Analyst @AnalystsAnalyst]

HHS Secretary Robert F. Kennedy Jr. has initiated changes targeting members of a CDC advisory committee responsible for vaccine approvals, raising concerns about future vaccine policies.

#vaccine #PublicHealth #RFKJrConfirmation
https://t.co/9cYwv0bFpn

[Analysts' Analyst @AnalystsAnalyst]

A measles outbreak in Texas and New Mexico has resulted in nearly 100 infections, primarily among unvaccinated children. Health officials are conducting contact tracing and offering free vaccinations to control the spread.

#Measles #PublicHealth
https://t.co/f4ZmDXHund

[Zack Capp @zackcapp]

As the antivax movement grows, so do the number of #Measles outbreaks across the US.

Good listen with @AdamRatnerMD

https://t.co/UgnAI6kF0m

[Analysts' Analyst @AnalystsAnalyst]

The recent confirmation of a 4th Clade 1 mpox case in New York underscores the urgent need for diversified vaccine supply chains. GeoVax is advancing its GEO-MVA vaccine to enhance U.S. and global readiness against this virulent strain.
#mpoxs #vaccines

https://t.co/PFHsL9i6a8

[Analysts' Analyst @AnalystsAnalyst]

Trump administration halts CDC's flu vaccine campaign. Despite a severe flu season, the successful immunization initiative has been terminated, raising public health concerns.

https://t.co/ua8ijuUmul
#CDC #vaccines #Immunology #Trump

[Analysts' Analyst @AnalystsAnalyst]

WHO's Immunization Director addresses global vaccine challenges. In a recent message, the director emphasized the need for strengthened surveillance and equitable vaccine access, especially in conflict zones.

https://t.co/hqlSL9kL01
#WHO #Immunology #GlobalHealth

[Analysts' Analyst @AnalystsAnalyst]

GeoVax has announced a Major Gedeptin Milestone with Plans for Phase 2 Trial. They continue to advance their novel cancer therapy for head and neck cancer patients.

https://t.co/oqebVZkwJu
#Cancer #CancerResearch #CancerAwareness #CancerCare #vaccines

[Analysts' Analyst @AnalystsAnalyst]

RFK Jr., a known vaccine skeptic, has been appointed to a position within the Department of Health and Human Services. This move could significantly change the CDC's vaccine advisory committee, influencing vaccine policy and public health recommendations.

https://t.co/pIgrbY4fHk

[Analysts' Analyst @AnalystsAnalyst]

Texas is having its most significant measles outbreak in nearly 30 years, with 48 confirmed cases, mainly in Gaines County. The outbreak has been linked to low vaccination rates in many communities. Vaccination is key.
#VaccinesSaveLives #vaccine #Measles
https://t.co/U5HK1IuTfW

[Analysts' Analyst @AnalystsAnalyst]

Trump has signed an executive order to withhold funds from schools requiring COVID-19 vaccinations. Most schools have already lifted mandates, but this order reinforces the administration's stance against vaccinations in educational settings.

#vaccine
https://t.co/jzHCNAdyt4

[Analysts' Analyst @AnalystsAnalyst]

GSK has received FDA approval for a vaccine designed to protect people aged 10 to 25 against five serogroups of meningococcal disease. This positions GSK alongside Pfizer in offering extensive meningococcal vaccination options.
#FDA #VaccinesSaveLives
https://t.co/tUlezxR07r

[Analysts' Analyst @AnalystsAnalyst]

Vaccine hesitancy is contributing to the most severe flu season in over 15 years. Vaccination remains a key measure in preventing the spread of influenza and reducing the burden on healthcare systems.

https://t.co/RO85HJqJhP
#vaccins #FLU #influenza #vaccineswork